Thryv Therapeutics
thryvtrx.comLocations
Laval, QC, Canada
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Seed
founded in
2019
Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.
Something looks off?Open jobs at Thryv Therapeutics
On-site & Remote
Job function
Salary